Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1989 Dec;82(12):747–752. doi: 10.1177/014107688908201216

Tell me about free radicals, doctor: a review.

B Halliwell 1
PMCID: PMC1292422  PMID: 2693713

Full text

PDF
747

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aruoma O. I., Bomford A., Polson R. J., Halliwell B. Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood. 1988 Oct;72(4):1416–1419. [PubMed] [Google Scholar]
  2. Baldwin S. R., Simon R. H., Grum C. M., Ketai L. H., Boxer L. A., Devall L. J. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet. 1986 Jan 4;1(8471):11–14. doi: 10.1016/s0140-6736(86)91895-7. [DOI] [PubMed] [Google Scholar]
  3. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol. 1988 Jul;12(1):239–249. doi: 10.1016/0735-1097(88)90381-6. [DOI] [PubMed] [Google Scholar]
  4. Breimer L. H. Ionizing radiation-induced mutagenesis. Br J Cancer. 1988 Jan;57(1):6–18. doi: 10.1038/bjc.1988.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7725–7729. doi: 10.1073/pnas.84.21.7725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Curnutte J. T., Babior B. M. Chronic granulomatous disease. Adv Hum Genet. 1987;16:229–297. doi: 10.1007/978-1-4757-0620-8_4. [DOI] [PubMed] [Google Scholar]
  7. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6(1):67–75. doi: 10.3109/10715768909073429. [DOI] [PubMed] [Google Scholar]
  8. Farr S. B., D'Ari R., Touati D. Oxygen-dependent mutagenesis in Escherichia coli lacking superoxide dismutase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8268–8272. doi: 10.1073/pnas.83.21.8268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gey K. F., Brubacher G. B., Stähelin H. B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr. 1987 May;45(5 Suppl):1368–1377. doi: 10.1093/ajcn/45.5.1368. [DOI] [PubMed] [Google Scholar]
  10. Gower J., Healing G., Green C. Measurement by HPLC of desferrioxamine-available iron in rabbit kidneys to assess the effect of ischaemia on the distribution of iron within the total pool. Free Radic Res Commun. 1989;5(4-5):291–299. doi: 10.3109/10715768909074713. [DOI] [PubMed] [Google Scholar]
  11. Gryglewski R. J., Palmer R. M., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986 Apr 3;320(6061):454–456. doi: 10.1038/320454a0. [DOI] [PubMed] [Google Scholar]
  12. Hall E. D. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats. J Neurosurg. 1988 Mar;68(3):462–465. doi: 10.3171/jns.1988.68.3.0462. [DOI] [PubMed] [Google Scholar]
  13. Hall E. D., Yonkers P. A. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke. 1988 Mar;19(3):340–344. doi: 10.1161/01.str.19.3.340. [DOI] [PubMed] [Google Scholar]
  14. Hall E. D., Yonkers P. A., McCall J. M., Braughler J. M. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg. 1988 Mar;68(3):456–461. doi: 10.3171/jns.1988.68.3.0456. [DOI] [PubMed] [Google Scholar]
  15. Halliwell B., Aruoma O. I., Mufti G., Bomford A. Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs. FEBS Lett. 1988 Dec 5;241(1-2):202–204. doi: 10.1016/0014-5793(88)81061-5. [DOI] [PubMed] [Google Scholar]
  16. Halliwell B., Gutteridge J. M. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet. 1984 Jun 23;1(8391):1396–1397. doi: 10.1016/s0140-6736(84)91886-5. [DOI] [PubMed] [Google Scholar]
  17. Halliwell B., Gutteridge J. M. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys. 1986 May 1;246(2):501–514. doi: 10.1016/0003-9861(86)90305-x. [DOI] [PubMed] [Google Scholar]
  18. Halliwell B., Gutteridge J. M. The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med. 1985;8(2):89–193. doi: 10.1016/0098-2997(85)90001-9. [DOI] [PubMed] [Google Scholar]
  19. Halliwell B., Hoult J. R., Blake D. R. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J. 1988 Oct;2(13):2867–2873. doi: 10.1096/fasebj.2.13.2844616. [DOI] [PubMed] [Google Scholar]
  20. Halliwell B. Lipid peroxidation in vivo and in vitro in relation to atherosclerosis: some fundamental questions. Agents Actions Suppl. 1988;26:223–231. [PubMed] [Google Scholar]
  21. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1987 Nov;1(5):358–364. [PubMed] [Google Scholar]
  22. Halliwell B. Superoxide, iron, vascular endothelium and reperfusion injury. Free Radic Res Commun. 1989;5(6):315–318. doi: 10.3109/10715768909073413. [DOI] [PubMed] [Google Scholar]
  23. Kettle A. J., Winterbourn C. C. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J. 1988 Jun 1;252(2):529–536. doi: 10.1042/bj2520529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kretzer F. L., Mehta R. S., Johnson A. T., Hunter D. G., Brown E. S., Hittner H. M. Vitamin E protects against retinopathy of prematurity through action on spindle cells. 1984 Jun 28-Jul 4Nature. 309(5971):793–795. doi: 10.1038/309793a0. [DOI] [PubMed] [Google Scholar]
  25. Levander O. A. A global view of human selenium nutrition. Annu Rev Nutr. 1987;7:227–250. doi: 10.1146/annurev.nu.07.070187.001303. [DOI] [PubMed] [Google Scholar]
  26. Marcillat O., Zhang Y., Lin S. W., Davies K. J. Mitochondria contain a proteolytic system which can recognize and degrade oxidatively-denatured proteins. Biochem J. 1988 Sep 15;254(3):677–683. doi: 10.1042/bj2540677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. McLaren G. D., Muir W. A., Kellermeyer R. W. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983;19(3):205–266. doi: 10.3109/10408368309165764. [DOI] [PubMed] [Google Scholar]
  28. Muller D. P., Lloyd J. K., Wolff O. H. Vitamin E and neurological function. Lancet. 1983 Jan 29;1(8318):225–228. doi: 10.1016/s0140-6736(83)92598-9. [DOI] [PubMed] [Google Scholar]
  29. Scott G. Potential toxicological problems associated with antioxidants in plastics and rubber consumables. Free Radic Res Commun. 1988;5(3):141–147. doi: 10.3109/10715768809066923. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES